These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 37311647

  • 1. Cognitive dysfunction and impaired neuroplasticity following repeated exposure to the synthetic cannabinoid JWH-018 in male mice.
    Bilel S, Zamberletti E, Caffino L, Tirri M, Mottarlini F, Arfè R, Barbieri M, Beggiato S, Boccuto F, Bernardi T, Casati S, Brini AT, Parolaro D, Rubino T, Ferraro L, Fumagalli F, Marti M.
    Br J Pharmacol; 2023 Nov; 180(21):2777-2801. PubMed ID: 37311647
    [Abstract] [Full Text] [Related]

  • 2. Elevation of endocannabinoids in the brain by synthetic cannabinoid JWH-018: mechanism and effect on learning and memory.
    Li RS, Fukumori R, Takeda T, Song Y, Morimoto S, Kikura-Hanajiri R, Yamaguchi T, Watanabe K, Aritake K, Tanaka Y, Yamada H, Yamamoto T, Ishii Y.
    Sci Rep; 2019 Jul 03; 9(1):9621. PubMed ID: 31270353
    [Abstract] [Full Text] [Related]

  • 3. CB1 receptor-mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH-081, a new component of spice/K2 preparations.
    Basavarajappa BS, Subbanna S.
    Hippocampus; 2014 Feb 03; 24(2):178-88. PubMed ID: 24123667
    [Abstract] [Full Text] [Related]

  • 4. Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence.
    Barbieri M, Ossato A, Canazza I, Trapella C, Borelli AC, Beggiato S, Rimondo C, Serpelloni G, Ferraro L, Marti M.
    Neuropharmacology; 2016 Oct 03; 109():254-269. PubMed ID: 27346209
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice.
    Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH.
    Neuropharmacology; 2017 Oct 03; 125():80-86. PubMed ID: 28673548
    [Abstract] [Full Text] [Related]

  • 7. Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes.
    Belluomo I, Matias I, Pernègre C, Marsicano G, Chaouloff F.
    J Neurochem; 2015 Apr 03; 133(1):26-37. PubMed ID: 25626460
    [Abstract] [Full Text] [Related]

  • 8. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
    Llorente-Berzal A, Terzian AL, di Marzo V, Micale V, Viveros MP, Wotjak CT.
    Psychopharmacology (Berl); 2015 Aug 03; 232(15):2811-25. PubMed ID: 25814137
    [Abstract] [Full Text] [Related]

  • 9. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG.
    Pharmacol Res; 2013 Jan 03; 67(1):94-109. PubMed ID: 23127915
    [Abstract] [Full Text] [Related]

  • 10. A role for the endocannabinoid system in exercise-induced spatial memory enhancement in mice.
    Ferreira-Vieira TH, Bastos CP, Pereira GS, Moreira FA, Massensini AR.
    Hippocampus; 2014 Jan 03; 24(1):79-88. PubMed ID: 24115292
    [Abstract] [Full Text] [Related]

  • 11. Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum.
    Ade KK, Lovinger DM.
    J Neurosci; 2007 Feb 28; 27(9):2403-9. PubMed ID: 17329438
    [Abstract] [Full Text] [Related]

  • 12. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R, Morello G, Luongo L, Taschler U, Romano R, De Gregorio D, Belardo C, Maione S, Di Marzo V, Cristino L.
    J Neurochem; 2015 Nov 28; 135(4):799-813. PubMed ID: 26223500
    [Abstract] [Full Text] [Related]

  • 13. Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ9 -tetrahydrocannabinol.
    Hoffman AF, Lycas MD, Kaczmarzyk JR, Spivak CE, Baumann MH, Lupica CR.
    Addict Biol; 2017 Mar 28; 22(2):390-399. PubMed ID: 26732435
    [Abstract] [Full Text] [Related]

  • 14. Cocaine-induced behavioral sensitization is associated with changes in the expression of endocannabinoid and glutamatergic signaling systems in the mouse prefrontal cortex.
    Blanco E, Pavón FJ, Palomino A, Luque-Rojas MJ, Serrano A, Rivera P, Bilbao A, Alen F, Vida M, Suárez J, Rodríguez de Fonseca F.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(1):. PubMed ID: 25539508
    [Abstract] [Full Text] [Related]

  • 15. Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.
    Tai S, Hyatt WS, Gu C, Franks LN, Vasiljevik T, Brents LK, Prather PL, Fantegrossi WE.
    Pharmacol Res; 2015 Dec 31; 102():22-32. PubMed ID: 26361728
    [Abstract] [Full Text] [Related]

  • 16. Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum.
    De Chiara V, Angelucci F, Rossi S, Musella A, Cavasinni F, Cantarella C, Mataluni G, Sacchetti L, Napolitano F, Castelli M, Caltagirone C, Bernardi G, Maccarrone M, Usiello A, Centonze D.
    J Neurosci; 2010 Jun 16; 30(24):8127-37. PubMed ID: 20554863
    [Abstract] [Full Text] [Related]

  • 17. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain.
    Leishman E, Cornett B, Spork K, Straiker A, Mackie K, Bradshaw HB.
    Pharmacol Res; 2016 Aug 16; 110():159-172. PubMed ID: 27109320
    [Abstract] [Full Text] [Related]

  • 18. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.
    Noya-Riobó MV, Miguel CÁ, Soriano DB, Brumovsky PR, Villar MJ, Coronel MF.
    Exp Neurol; 2023 Jan 16; 359():114232. PubMed ID: 36179876
    [Abstract] [Full Text] [Related]

  • 19. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
    Dowie MJ, Bradshaw HB, Howard ML, Nicholson LF, Faull RL, Hannan AJ, Glass M.
    Neuroscience; 2009 Sep 29; 163(1):456-65. PubMed ID: 19524019
    [Abstract] [Full Text] [Related]

  • 20. The influence of cannabinoids on learning and memory processes of the dorsal striatum.
    Goodman J, Packard MG.
    Neurobiol Learn Mem; 2015 Nov 29; 125():1-14. PubMed ID: 26092091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.